- Home
- SELF vs CLSD Comparison
SELF vs CLSD Comparison
Compare SELF & CLSD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SELF
- CLSD
- Stock Information
- Founded
- SELF 1983
- CLSD 2011
- Country
- SELF United States
- CLSD United States
- Employees
- SELF N/A
- CLSD N/A
- Industry
- SELF Real Estate Investment Trusts
- CLSD Biotechnology: Pharmaceutical Preparations
- Sector
- SELF Real Estate
- CLSD Health Care
- Exchange
- SELF Nasdaq
- CLSD Nasdaq
- Market Cap
- SELF 58.8M
- CLSD 68.4M
- IPO Year
- SELF N/A
- CLSD 2016
- Fundamental
- Price
- SELF $5.15
- CLSD $0.35
- Analyst Decision
- SELF
- CLSD Hold
- Analyst Count
- SELF 0
- CLSD 4
- Target Price
- SELF N/A
- CLSD $4.33
- AVG Volume (30 Days)
- SELF 36.6K
- CLSD 582.0K
- Earning Date
- SELF 11-07-2025
- CLSD 08-08-2025
- Dividend Yield
- SELF 5.61%
- CLSD N/A
- EPS Growth
- SELF 9.99
- CLSD N/A
- EPS
- SELF 0.22
- CLSD N/A
- Revenue
- SELF $12,707,884.00
- CLSD $4,166,000.00
- Revenue This Year
- SELF N/A
- CLSD $98.20
- Revenue Next Year
- SELF N/A
- CLSD $213.77
- P/E Ratio
- SELF $23.87
- CLSD N/A
- Revenue Growth
- SELF 4.08
- CLSD N/A
- 52 Week Low
- SELF $4.78
- CLSD $0.29
- 52 Week High
- SELF $5.89
- CLSD $1.65
- Technical
- Relative Strength Index (RSI)
- SELF 45.23
- CLSD 33.25
- Support Level
- SELF $5.11
- CLSD $0.39
- Resistance Level
- SELF $5.51
- CLSD $0.36
- Average True Range (ATR)
- SELF 0.14
- CLSD 0.03
- MACD
- SELF -0.00
- CLSD 0.00
- Stochastic Oscillator
- SELF 25.00
- CLSD 14.77
About SELF Global Self Storage Inc.
Global Self Storage Inc is a self-administered and self-managed REIT that owns, operates, manages, acquires, develops, and redevelops self-storage properties. The company's self-storage properties are designed to offer affordable, easily accessible, and secure storage space for residential and commercial customers. It has one segment of Rental operations. Through its wholly-owned subsidiaries, the company owns and/or manages close to thirteen self-storage properties in Connecticut, Illinois, Indiana, New York, Ohio, Pennsylvania, South Carolina, and Oklahoma.
About CLSD Clearside Biomedical Inc.
Clearside Biomedical Inc is a United States-based clinical biopharmaceutical company. It is engaged in developing pharmacological therapies to treat blinding disease of the eye through the suprachoroidal space, or SCS. The company's novel SCS injection platform, utilizing a proprietary SCS Microinjector, enables an in-office, repeatable, non-surgical procedure for the targeted and compartmentalized delivery of a wide variety of therapies to the macula, retina, or choroid to potentially preserve and improve vision in patients with sight-threatening eye diseases.